Biosimilar Equal to Natalizumab for Relapsing-Remitting MS ...Middle East

A novel biosimilar matches natalizumab in terms of efficacy, safety, and immunogenicity in patients with relapsing remitting multiple sclerosis, results from a new phase 3 trial show. Medscape Medical News

Hence then, the article about biosimilar equal to natalizumab for relapsing remitting ms was published today ( Friday 27/01/2023 - 07:24 PM ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Biosimilar Equal to Natalizumab for Relapsing-Remitting MS )

Also on site :

• I-70 closed in Glenwood Canyon for safety concerns, police activity
• Russian cat becomes world champion 2025
• 2 dead, 1 injured in overnight Westminster house fire